CISPLATIN NEPHROTOXICITY

被引：109

作者：

FILLASTRE, JP

RAGUENEZVIOTTE, G

机构：

来源：

TOXICOLOGY LETTERS | 1989年 / 46卷 / 1-3期

关键词：

D O I：

10.1016/0378-4274(89)90125-2

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：163 / 175

页数：13

共 62 条

[1]

AGGARWAL SK, 1980, CISPLATIN CURRENT ST, P79

[2]

ANDERSON T, 1979, CANCER TREAT REP, V63, P1687

[3]

BELT RJ, 1979, P AM ASSOC CANC RES, V20, P388

[4] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN [J].

BLACHLEY, JD ;

HILL, JB .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) :628-632

[5]

BUAMAH PK, 1982, CANCER CHEMOTH PHARM, V8, P281

[6] HYPOMAGNESEMIA AFTER CISPLATIN COMBINATION CHEMOTHERAPY [J].

BUCKLEY, JE ;

CLARK, VL ;

MEYER, TJ ;

PEARLMAN, NW .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (12) :2347-2348

[7] CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE [J].

CANETTA, R ;

ROZENCWEIG, M ;

CARTER, SK .

CANCER TREATMENT REVIEWS, 1985, 12 :125-136

[8]

CHARY K K, 1977, Journal of Clinical Hematology and Oncology, V7, P633

[9] SUBCELLULAR-LOCALIZATION OF CIS-DICHLORODIAMMINEPLATINUM(II) IN RAT-KIDNEY AND LIVER [J].

CHOIE, DD ;

DELCAMPO, AA ;

GUARINO, AM .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 55 (02) :245-252

[10]

COHEN AI, 1980, P AM ASSOC CANC RES, V21, P137

← 1 2 3 4 5 6 7 →